Get 20% Free Customization In This Report

Buy this report from - $3456

Heparin Sodium Market by Type (Unfractionated Heparin, Low molecular weight heparins, and Heparinoids), and by Application (Venous Thromboembolism, Complications of Pregnancy, Cardioversion of Atrial Fibrillation/Flutter, and Others) - Global Opportunity Analysis and Industry Forecast 2017-2023

Medical Devices & Supplies	LI_183477	Pages: NA	Jul 2018 \| 695 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Heparin sodium is an anticoagulant that is used to prevent blood clots. It is also known as a blood thinner. Heparin sodium is used to treat blood clot formation in the lungs, arteries, and veins. Heparin sodium is also used prior to a surgery to reduce the risk of blood clots.

The major factors that drive the growth of the global heparin sodium market are increase in the incidence of thrombosis, rise in government funding towards improving healthcare facilities, and rising awareness among the patient population regarding the availability of such treatment options. However, stringent government regulations and lack of awareness among the patient population regarding the availability of such treatment options restrict the market growth. However, unmet medical needs in emerging economies attract key players to invest on healthcare treatment modalities. This is anticipated to provide lucrative growth opportunities for the global heparin sodium market.

The global heparin sodium market is segmented on the basis of type and application. Based on type, the market is categorised into unfractionated heparin, low molecular weight heparins, and heparinoids. In terms of application, the market is divided into venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter, and others. Regionally, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players of the market are Shenzhen Hepalink, Sichuan Deebio Pharmaceutical Co.LTD., Nanjing Xinbai Pharmaceutical Co., Ltd., Hebei Changshan Biochemical Pharmaceutical Co., Ltd, Yantai Dongcheng Biochemicals Co. Ltd., Pharma Action GmbH, Opocrin S.p.A, Bioibrica, Aspen Oss BV, and Pfizer Inc.

Key Benefits

The study provides an in-depth analysis of the global heparin sodium market along with the current trends and future estimations to elucidate imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth has been provided in the report.
Comprehensive quantitative analysis of the industry has been provided from 20162023 to assist stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of key segments of the industry helps understand the trends in the types of heparin sodium globally.
Key market players and their strategies have been provided to understand the competitive outlook of the industry.

Heparin Sodium Market Key Segments:

By Type

Unfractionated Heparin
Low Molecular Weight Heparins
Heparinoids

By Application

Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Argentina
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 HEPARIN SODIUM MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. UNFRACTIONATED HEPARIN

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. LOW MOLECULAR WEIGHT HEPARINS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. HEPARINOIDS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 HEPARIN SODIUM MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. VENOUS THROMBOEMBOLISM

5.2.1. Key market trends

5.3. COMPLICATIONS OF PREGNANCY

5.3.1. Key market trends

5.4. CARDIOVERSION OF ATRIAL FIBRILLATION/FLUTTER

5.4.1. Key market trends

5.5. OTHERS

5.5.1. Key market trends

Chapter: 6 HEPARIN SODIUM MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Heparin Sodium Market by Type
6.2.5. North America Heparin Sodium Market by Application

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast

6.3.4. Europe Heparin Sodium Market by Type
6.3.5. Europe Heparin Sodium Market by Application

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Heparin Sodium Market by Type
6.4.5. Asia-Pacific Heparin Sodium Market by Application

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Heparin Sodium Market by Type
6.5.5. LAMEA Heparin Sodium Market by Application

Chapter: 7 COMPANY PROFILES

7.1. SHENZHEN HEPALINK

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. ICHUAN DEEBIO PHARMACEUTICAL CO.LTD.

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. NANJING XINBAI PHARMACEUTICAL CO., LTD.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. YANTAI DONGCHENG BIOCHEMICALS CO.LTD.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. PHARMA ACTION GMBH

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. OPOCRIN S.P.A

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. BIOIBÉRICA

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. ASPEN OSS BV

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. PFIZER INC.

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Heparin Sodium Market by Type (Unfractionated Heparin, Low molecular weight heparins, and Heparinoids), and by Application (Venous Thromboembolism, Complications of Pregnancy, Cardioversion of Atrial Fibrillation/Flutter, and Others) - Global Opportunity Analysis and Industry Forecast 2017-2023